Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PIG-A Inhibitors

PIG-A, also known as phosphatidylinositol glycan anchor biosynthesis class A protein, is a critical enzyme involved in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors. GPI anchors are essential for anchoring various proteins to the cell membrane, thereby facilitating their proper localization and functioning. PIG-A catalyzes the first step in GPI anchor biosynthesis by transferring N-acetylglucosamine (GlcNAc) to phosphatidylinositol, initiating the assembly of the GPI precursor. This enzymatic reaction serves as a key regulatory step in the GPI biosynthetic pathway, dictating the subsequent modifications and processing events required for the generation of mature GPI anchors. Additionally, PIG-A deficiency or dysfunction leads to the loss of GPI anchors on cell surface proteins, resulting in the impairment of cellular adhesion, signal transduction, and immune responses.

Inhibition of PIG-A activity represents a strategy for modulating GPI anchor biosynthesis and disrupting the functions of GPI-anchored proteins. One approach to inhibiting PIG-A involves targeting its catalytic site or active site residues, thereby interfering with its enzymatic activity and inhibiting the transfer of GlcNAc to phosphatidylinositol. Small molecule inhibitors designed to mimic the substrate or transition state of the PIG-A catalytic reaction may competitively bind to the enzyme, blocking its access to the substrate and impeding GPI anchor biosynthesis. Alternatively, inhibition of upstream regulators or downstream effectors of PIG-A could also modulate GPI anchor biosynthesis indirectly. For example, targeting enzymes involved in the synthesis or transport of GPI precursor molecules may limit substrate availability for PIG-A, leading to the inhibition of GPI anchor biosynthesis. Overall, inhibition of PIG-A activity offers a promising avenue for investigating the roles of GPI anchors in cellular processes and exploring possible interventions targeting GPI-anchored protein function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Swainsonine

72741-87-8sc-201362
sc-201362C
sc-201362A
sc-201362D
sc-201362B
1 mg
2 mg
5 mg
10 mg
25 mg
$138.00
$251.00
$631.00
$815.00
$1832.00
6
(1)

An inhibitor of glycoprotein processing, could impact GPI anchor formation involving PIG-A.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Inhibits N-linked glycosylation, potentially disrupting GPI-anchor synthesis where PIG-A is involved.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts Golgi apparatus function, indirectly affecting GPI anchor biosynthesis and PIG-A activity.

Castanospermine

79831-76-8sc-201358
sc-201358A
100 mg
500 mg
$184.00
$632.00
10
(1)

An inhibitor of glucosidase I and II, could impact glycan processing in GPI anchor synthesis involving PIG-A.

Fumonisin B1

116355-83-0sc-201395
sc-201395A
1 mg
5 mg
$200.00
$680.00
18
(1)

Inhibits ceramide synthase, potentially affecting lipid components crucial for GPI anchor biosynthesis by PIG-A.

Myriocin (ISP-1)

35891-70-4sc-201397
10 mg
$150.00
8
(2)

A sphingolipid synthesis inhibitor, could indirectly affect GPI anchor synthesis involving PIG-A.

Cerulenin (synthetic)

17397-89-6sc-200827
sc-200827A
sc-200827B
5 mg
10 mg
50 mg
$161.00
$312.00
$1210.00
9
(1)

Inhibits fatty acid synthesis, potentially impacting lipid synthesis necessary for GPI anchor formation by PIG-A.

Tipifarnib

192185-72-1sc-364637
10 mg
$720.00
(0)

Inhibits farnesyltransferase, might indirectly affect post-translational modifications in proteins associated with PIG-A.